Nope, I never made that statement as a stand alone. Do not
Nope, I never made that statement as a stand alone. Do not take statements out of context. Again please stop making excuses for the company and blaming shareholders for the company's poor performance. That type of thinking has enabled the company to continue with its never ending "extended time lines".
I have gone on record that I believe the 5M hits this month. If it does not happen and you are OK with more BS excuses, then I can only wonder and I may be a little worried about you.
Hopefully we all can celebrate a bit of good news when the receipt of the 5M loan is announced some time this month.
4
Nanotech Entertainment Inc. (NTEK) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Revolutionizing Cloud Mining with BCC Mining Cloud mining has witnessed significant advancements, particularly with the recent introduction of BCC Mining's mobile app. This development marks a new era for cryptocurrency enthusiasts, making it easier than ever to participate in mining activities. Users now have the flexibility to manage their mining operations from...
Continue Reading
CEFALY Introduces the Pregnancy Registry for Migraine Treatment Medical device company CEFALY Technology has recently announced the introduction of the CEFALY Pregnancy Registry, a research initiative aimed at assessing the safety of external trigeminal nerve stimulation (eTNS) for migraine treatment during pregnancy. The Challenge of Managing Migraines During Pregnancy...
Continue Reading
Velocity MSC Expands Offerings with Innovative 5G Communication Solution Velocity MSC, a trusted name in technological solutions, has announced an exciting addition to its service lineup. The company has incorporated DataRemote's advanced 90X1 5G Plain Old Telephone Service (POTS) replacement solution into its existing offerings. This innovative solution aligns with...
Continue Reading
Interleukin-23 Inhibitors Market Overview The interleukin-23 inhibitors market is currently experiencing significant growth, fueled by the escalating prevalence of autoimmune diseases such as psoriasis and inflammatory bowel disease. With innovations in biologics and increasing acceptance of targeted therapies, the demand for these treatments continues to surge....
Continue Reading
Hexagon Plans Spin-Off for Enhanced Focus and Growth Hexagon AB is embarking on an exciting journey towards the spin-off of its Asset Lifecycle Intelligence (ALI) division and associated businesses. This significant decision, made by the Board of Directors, aims to separate ALI into a new entity that will allow both Hexagon and the new organization, referred to as NewCo,...
Continue Reading
